About GenMark Diagnostics

genmarkdx.com

GenMark Diagnostics is a provider of automated, multiplex molecular diagnostic testing systems.

Revenue : 100M-200M Industry : Medical Devices Location : United States Employees : 200-500

SaaS Adoption

SaaS Adoption indicates the level of adoption by this company of software as a service services.

Cloud Adoption

Cloud Adoption indicates the level of adoption by this company of cloud services.

IT Footprint

IT Footprint gives a relative indication of how much IT services this company consumes.

IT Spend

IT Spend shows roughly how much this client spends on IT per year in USD.

Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.

Know the products your prospects use

Enlyft provides you with access to our real-time data platform where you can access insights into a company’s tech stack, firmographic data, and more.

Vendor Usage

GenMark Diagnostics uses 5 different technologies from 42 different vendors. They have above average use of several technologies including VMware vSphere, Salesforce.com CRM and MasterControl.

Product Categories

GenMark Diagnostics uses products from 41 different product categories. They are particularly heavy users of products in Database Management System, Software Development Tools, and Cloud Platforms & Services.

Recently Detected Technologies

Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.

Technology Category Vendor Usage
VMware vSphere Virtualization Platforms VMware, Inc
OpenX Ad Servers OpenX
MasterControl Enterprise GRC MasterControl
SAP Data Migration Data Integration SAP
Google Compute Engine Cloud Platforms & Services Google LLC

Are you interested in knowing other companies with similar tech stacks?

Reveal what vendors your prospects are using

Enlyft Sales Insights gives you instant access to the tech stack and firmographics of millions of companies worldwide.
Logos provided by Clearbit

© Enlyft | All rights reserved.